-
RC213-15.SIZE.500UEPO, human: Human Erythropoietin Erythropoietin (EPO), a glycoprotein produced primarily by the kidney, is the principal factor that regulates erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells. The
-
RC213-15B.SIZE.10ugEPO-Fc, human: Erythropoietin (EPO), a glycoprotein produced primarily by the kidney, is the principal factor that regulates erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells. The production of EPO by
-
RC213-15B.SIZE.1mgEPO-Fc, human: Erythropoietin (EPO), a glycoprotein produced primarily by the kidney, is the principal factor that regulates erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells. The production of EPO by
-
RC213-15B.SIZE.2ugEPO-Fc, human: Erythropoietin (EPO), a glycoprotein produced primarily by the kidney, is the principal factor that regulates erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells. The production of EPO by
-
RC315-32.SIZE.1mgExodus-2, CCL21, human: Exodus-2/CCL21 is a novel CC chemokine discovered independently by three groups from the EST database and shows 21-33% identity to other CC chemokines. Exodus-2 contains the four conserved cysteines characteristic of &beta
-
RC315-32.SIZE.20ugExodus-2, CCL21, human: Exodus-2/CCL21 is a novel CC chemokine discovered independently by three groups from the EST database and shows 21-33% identity to other CC chemokines. Exodus-2 contains the four conserved cysteines characteristic of &beta
-
RC315-32.SIZE.5ugExodus-2, CCL21, human: Exodus-2/CCL21 is a novel CC chemokine discovered independently by three groups from the EST database and shows 21-33% identity to other CC chemokines. Exodus-2 contains the four conserved cysteines characteristic of &beta
-
RC214-16.SIZE.10ugFlt3-Ligand, CX3CL1, human: Flt-3 ligand (FL) is a recently identified hematopoietic cytokine whose activities are mediated by binding to the transmembrane glycoprotein Flt-3. Flt-3 was first discovered as a member of the class III subfamily of
-
RC214-16.SIZE.1mgFlt3-Ligand, CX3CL1, human: Flt-3 ligand (FL) is a recently identified hematopoietic cytokine whose activities are mediated by binding to the transmembrane glycoprotein Flt-3. Flt-3 was first discovered as a member of the class III subfamily of
-
RC214-16.SIZE.2ugFlt3-Ligand, CX3CL1, human: Flt-3 ligand (FL) is a recently identified hematopoietic cytokine whose activities are mediated by binding to the transmembrane glycoprotein Flt-3. Flt-3 was first discovered as a member of the class III subfamily of
-
RC314-12.SIZE.1mgFractalkine, CX3CL1, human: Fractalkine, also named neurotactin, is a novel chemokine recently identified through bioinformatics. Fractalkine has a unique C-X3-C cysteine motif near the amino-terminus and is the first member of a fourth branch of
-
RC314-12.SIZE.20ugFractalkine, CX3CL1, human: Fractalkine, also named neurotactin, is a novel chemokine recently identified through bioinformatics. Fractalkine has a unique C-X3-C cysteine motif near the amino-terminus and is the first member of a fourth branch of